|
Harry A. Milman, Ph.D. |
|
Dr. Milman is often called for "on air" television and radio interviews on matters related to toxicology and carcinogenicity of environmental pollutants. Furthermore, Dr. Milman has provided support to public relations firms and print and electronic news media to better understand scientific findings, disseminate scientific information in an understandable fashion and in writing and editing. Prior to embarking on his consulting activities, Dr. Milman served for nearly 20 years at the US Environmental Protection Agency (EPA) as a Senior Toxicologist and Senior Science Advisor. In the Office of Pollution Prevention and Toxic Substances (OPPT), Dr. Milman evaluated over 200 cancer and toxicology studies, including those on formaldehyde, and performed many health assessments under Sections 4, 5 and 6 of the Toxic Substances Control Act (TSCA). Dr. Milman managed the preparation of preliminary guidelines for "Risk-Risk Tradeoff" and implemented a research program on the use of biochemical and immunological markers as early indicators of cancer. As Chairman of the Health Research Subcommittee of the Office of Toxic Substances, Dr. Milman directed agency research priorities and coordinated scientific activities between the EPA, the National Toxicology Program (NTP), the Agency for Toxic Substances and Disease Registry (ATSDR), and national and international health organizations. While in the Office of International Activities, Dr. Milman coordinated agency participation in the World Health Organization (WHO), the Organization for Economic Cooperation and Development (OECD), and the International Program on Chemical Safety (IPCS), as well as provided guidance to the regulated industry involved in international transport of hazardous wastes. Dr. Milman spent ten years as a research scientist at the National Cancer Institute (NCI) of the National Institutes of Health (NIH). In the Laboratory of Toxicology, Dr. Milman conducted research on cancer treatment, childhood leukemia, and pancreatic cancer. Subsequently, in the Carcinogenesis Testing Program, he designed, managed, and monitored long-term animal cancer and toxicology studies. Dr. Milman was also licensed in pharmacy for over 35 years and was the first pharmacist at the White Earth Indian Health Center in Minnesota. Dr. Milman is past President of the National Capital Area Chapter of the Society of Toxicology ('05-'06) and a member of the Society of Toxicology (SOT), the American Society for Pharmacology and Experimental Therapeutics (ASPET) and the American Pharmacists Association (APhA). Dr. Milman has organized or presented at more than 25 national or international conferences, has edited five books, including the widely used Handbook of Carcinogen Testing, has authored over 70 scientific papers and abstracts, and has authored or reviewed numerous governmental reports.
Contact:
© Copyright
2000; 2005 ToxNetwork.com |
Dr.
Harry Milman has been consulting and assisting law firms in Toxicology, Carcinogenesis,
Pharmacology, and Pharmacy Standard of Care since 1998 after a distinguished career in the United States
Federal government. Some of Dr. Milman’s activities include
litigation support and expert witness testimony for Defense and Plaintiff,
including depositions and jury trials, as well as evaluation of medical
and pre-clinical pharmacology and toxicology information and media assistance. In
addition, Dr. Milman has evaluated science issues dealing with endocrine
disruption and bisphenol-A (BPA), DEHP and phthalates,
children’s health, benzene, formaldehyde, lead, trichloroethylene (TCE) and perchloroethylene
(PERC),
litihium, morphine, and cocaine, among many others.